Quanzhou Luo

Quanzhou Luo currently serves as Senior Director of CMC Management at WuXi Biologics, a position held since February 2022. Prior to this role, Quanzhou Luo accumulated extensive experience at Amgen from December 2008 to February 2022, advancing through the ranks as Principal Scientist, Senior Scientist, and Scientist. Earlier career milestones include serving as Senior Research Scientist at Northeastern University from April 2006 to December 2008 and completing a postdoctoral fellowship at Lawrence Berkeley National Laboratory in 2002-2003. Quanzhou Luo earned a PhD in Analytical Chemistry from the Dalian Institute of Chemical Physics between 1999 and 2002.